Accelerate regulatory submission prep and eliminate batch record auditing bottlenecks with GxP compliance-ready secure AI agents.
Pharmaceutical AI Solutions deliver GxP-compliant automation for regulatory batch record reviews, submission validation, and continuous audit readiness across drug manufacturing pipelines.
Pharmaceutical AI Automation is a suite of AI agents engineered for pharmaceutical and life sciences organizations. It automates FDA 21 CFR Part 11 compliant document validation, batch record auditing, and safety reporting loops, significantly reducing manual compliance review overhead.
| Compliance Dimension | Verified Platform Specification | Regulatory Impact |
|---|---|---|
| Regulatory Standards | FDA 21 CFR Part 11, EU Annex 11, EU GMP Guidelines | GxP validation ready |
| Review Acceleration | Dossier and batch record auditing cut from 7 days to 2 days | 75% processing cycle reduction |
| Audit Trail Logging | Immutable electronic signature logs and deviation checkpoint tracking | Tamper-proof QA records |
| Document & Contract Verification | Line-item extraction, SOP deviation auditing, PII/PHI redaction | 98% extraction precision |
| Deployment & Security | Cloud Native, Hybrid On-Premises, Air-Gapped Private VPC | HIPAA & SOC 2 Type II Support |
Answers to key questions regarding GxP batch record auditing, FDA compliance, and submission prep.
Sweya provides GxP compliance-ready AI agents to automate batch record auditing, accelerate regulatory submission preparation, and streamline document verification.
Sweya AI agents parse complex batch records, cross-reference operational parameters against regulatory guidelines, and flag anomalies prior to official quality assurance review.
Yes, Sweya pharma solutions feature 21 CFR Part 11 compliant electronic signatures, audit trails, and immutable record retention.
AI agents extract, format, and audit complex technical data across clinical dossiers, reducing manual preparation cycles for regulatory submissions.